Evidence map›Paper›PMID 38542104›Full record

ArticleInternational journal of molecular sciences2024

Correlation of Presynaptic and Postsynaptic Proteins with Pathology in Alzheimer's Disease.

Geidy E Serrano, Jessica Walker, Courtney Nelson, Michael Glass, Richard Arce, Anthony Intorcia, Madison P Cline, Natalie Nabaty, Amanda Acuña, Ashton Huppert Steed and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Geidy E SerranoCivin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Jessica WalkerCivin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Courtney NelsonCivin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Michael GlassCivin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Richard ArceCivin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Anthony IntorciaCivin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Madison P ClineCivin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Natalie NabatyCivin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Amanda AcuñaCivin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.ORCID 0009-0008-5713-9026
Ashton Huppert SteedCivin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Lucia I SueCivin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Christine BeldenCleo Roberts Center, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Parichita ChoudhuryCleo Roberts Center, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Eric ReimanThe Banner Alzheimer's Institute, Phoenix, AZ 85006, USA.
Alireza AtriCleo Roberts Center, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Thomas G BeachCivin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
Banner Sun Health Research Institute · USAlzheimer's Association · US

Funding

Research Education ComponentP30AG019610 · NIA · SUN HEALTH RESEARCH INSTITUTE · PI REIMAN, ERIC MICHAEL · 2001 to 2020
$32.5M
Research Education ComponentP30AG072980 · NIA · BANNER HEALTH · PI Nicholas Ashton · 2021 to 2026
$24.9M
National Brain and Tissue Resource for Parkinson's Disease and Related DisordersU24NS072026 · NINDS · BANNER SUN HEALTH RESEARCH INSTITUTE · PI BEACH, THOMAS G · 2011 to 2015
$7.8M
NIA NIH HHS P30 AG019610NIA NIH HHS P30 AG072980NIH HHS P30AG072980NIH HHS P30 AG19610NINDS NIH HHS U24 NS072026
6 · The paper itself

Abstract

Synaptic transmission is essential for nervous system function and the loss of synapses is a known major contributor to dementia. Alzheimer's disease dementia (ADD) is characterized by synaptic loss in the mesial temporal lobe and cerebral neocortex, both of which are brain areas associated with memory and cognition. The association of synaptic loss and ADD was established in the late 1980s, and it has been estimated that 30-50% of neocortical synaptic protein is lost in ADD, but there has not yet been a quantitative profiling of different synaptic proteins in different brain regions in ADD from the same individuals. Very recently, positron emission tomography (PET) imaging of synapses is being developed, accelerating the focus on the role of synaptic loss in ADD and other conditions. In this study, we quantified the densities of two synaptic proteins, the presynaptic protein Synaptosome Associated Protein 25 (SNAP25) and the postsynaptic protein postsynaptic density protein 95 (PSD95) in the human brain, using enzyme-linked immunosorbent assays (ELISA). Protein was extracted from the cingulate gyrus, hippocampus, frontal, primary visual, and entorhinal cortex from cognitively unimpaired controls, subjects with mild cognitive impairment (MCI), and subjects with dementia that have different levels of Alzheimer's pathology. SNAP25 is significantly reduced in ADD when compared to controls in the frontal cortex, visual cortex, and cingulate, while the hippocampus showed a smaller, non-significant reduction, and entorhinal cortex concentrations were not different. In contrast, all brain areas showed lower PSD95 concentrations in ADD when compared to controls without dementia, although in the hippocampus, this failed to reach significance. Interestingly, cognitively unimpaired cases with high levels of AD pathology had higher levels of both synaptic proteins in all brain regions. SNAP25 and PSD95 concentrations significantly correlated with densities of neurofibrillary tangles, amyloid plaques, and Mini Mental State Examination (MMSE) scores. Our results suggest that synaptic transmission is affected by ADD in multiple brain regions. The differences were less marked in the entorhinal cortex and the hippocampus, most likely due to a ceiling effect imposed by the very early development of neurofibrillary tangles in older people in these brain regions.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAgedBrainHumansNeurofibrillary TanglesPositron-Emission Tomographytau Proteinstau Proteinsagingamyloid plaquesBraak stagecerebral cortexneurofibrillary tanglespositron emission tomography (PET) imagingPSD95SNAP25

Identifiers

PMID38542104
PMCPMC10970005
OpenAlexW4392588697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.